Related references
Note: Only part of the references are listed.A guide to: generation and design of nanobodies
Serge Muyldermans
FEBS JOURNAL (2021)
The Next Generation of Influenza Vaccines: Towards a Universal Solution
Christopher L. D. McMillan et al.
VACCINES (2021)
Evolving AAV-delivered therapeutics towards ultimate cures
Xiangjun He et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
Immunogenicity Risk Profile of Nanobodies
Chloe Ackaert et al.
FRONTIERS IN IMMUNOLOGY (2021)
Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD-L1 and CTLA-4
Chunjuan Jiang et al.
ADVANCED SCIENCE (2021)
Physicochemical Stability of Monoclonal Antibodies: A Review
Yoann Le Basle et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Adeno-Associated Viral Vector Mediated Expression of Broadly-Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target
Chringma Sherpa et al.
CURRENT HIV RESEARCH (2020)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Engineering adeno-associated virus vectors for gene therapy
Chengwen Li et al.
NATURE REVIEWS GENETICS (2020)
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Margaux Teil et al.
BIOMOLECULES (2020)
Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors
Elena Barbon et al.
EMBO MOLECULAR MEDICINE (2020)
Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity
Joanne Marie M. Del Rosario et al.
FRONTIERS IN IMMUNOLOGY (2020)
Generation of synthetic nanobodies against delicate proteins
Iwan Zimmermann et al.
NATURE PROTOCOLS (2020)
Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?
Steven Rockman et al.
VACCINES (2020)
Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
Emily Y. Yang et al.
FRONTIERS IN ONCOLOGY (2020)
Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
Mrityunjoy Biswas et al.
VACCINES (2020)
Synthetic nanobodies as angiotensin receptor blockers
Conor McMahon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Anti-ADAMTS-5 Nanobody(R)M6495 Protects Cartilage Degradation Ex Vivo
Anne Sofie Siebuhr et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Leo Hanke et al.
NATURE COMMUNICATIONS (2020)
Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
Melanie Demeules et al.
FRONTIERS IN ONCOLOGY (2020)
Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity
Noelia Silva-Pilipich et al.
BIOMEDICINES (2020)
Hedgehog pathway activation through nanobody-mediated conformational blockade of the Patched sterol conduit
Yunxiao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Michael Schoof et al.
SCIENCE (2020)
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang et al.
SCIENCE (2020)
Alzheimer's disease: Recent treatment strategies
Miguel Vaz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
The Increasingly Human and Profitable Monoclonal Antibody Market
Antonio L. Grilo et al.
TRENDS IN BIOTECHNOLOGY (2019)
Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in rats
Tian Li et al.
FASEB JOURNAL (2019)
Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease
Michiel Van Bulck et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin 17A/F nanobody, in moderate-to-severe
Danka Svecova et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial
Frances H. Priddy et al.
LANCET HIV (2019)
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
Allison M. Keeler et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Selection of Functional Intracellular Nanobodies
James Woods
SLAS DISCOVERY (2019)
Hemophilia Gene Therapy: New Development from Bench to Bed Side
Xiao-Lu Guo et al.
CURRENT GENE THERAPY (2019)
Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice
Svetlana A. Godakova et al.
TOXINS (2019)
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
Anna Marei Eichhoff et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
Elena De Marchi et al.
ONCOGENE (2019)
Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies
Starlynn C. Clarke et al.
FRONTIERS IN IMMUNOLOGY (2019)
9 Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery
Pieterjan Debie et al.
ANTIBODIES (2019)
Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections
Lucas Wilken et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2018)
Novel half-life extended anti-MIF nanobodies protect against endotoxic shock
Amanda Sparkes et al.
FASEB JOURNAL (2018)
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
Guangyu Zhao et al.
JOURNAL OF VIROLOGY (2018)
The structural basis of nanobody unfolding reversibility and thermoresistance
Patrick Kunz et al.
SCIENTIFIC REPORTS (2018)
Pharmacology of Recombinant Adeno-associated Virus Production
Magalie Penaud-Budloo et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Intercellular Spread of Protein Aggregates in Neurodegenerative Disease
Albert A. Davis et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 34 (2018)
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
Nick S. Laursen et al.
SCIENCE (2018)
Single-Domain Antibodies and Their Formatting to Combat Viral Infections
Dorien De Vlieger et al.
ANTIBODIES (2018)
Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction
Wenwei Shao et al.
JCI INSIGHT (2018)
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
Laura M. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model
Diptaman Chatterjee et al.
NPJ PARKINSONS DISEASE (2018)
Expression of single-domain antibody in different systems
Yongkang Liu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects
Rong Shi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Therapeutic approaches to target alpha-synuclein pathology
Patrik Brundin et al.
EXPERIMENTAL NEUROLOGY (2017)
S/MAR Element Facilitates Episomal Long-Term Persistence of Adeno-Associated Virus Vector Genomes in Proliferating Cells
Claudia Hagedorn et al.
HUMAN GENE THERAPY (2017)
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Mario Sznol et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
State of play and clinical prospects of antibody gene transfer
Kevin Hollevoet et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Ablynx's nanobody fragments go places antibodies cannot
Cormac Sheridan
NATURE BIOTECHNOLOGY (2017)
Single domain antibodies for the knockdown of cytosolic and nuclear proteins
Thomas Boeldicke
PROTEIN SCIENCE (2017)
Pathology of Neurodegenerative Diseases
Brittany N. Dugger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
Iebe Rossey et al.
NATURE COMMUNICATIONS (2017)
In vivo mouse and live cell STED microscopy of neuronal actin plasticity using far-red emitting fluorescent proteins
Waja Wegner et al.
SCIENTIFIC REPORTS (2017)
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
Peter Bannas et al.
FRONTIERS IN IMMUNOLOGY (2017)
Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade
Fei Zhang et al.
CELL DISCOVERY (2017)
Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system
Yanan Cui et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
Universal influenza virus vaccines and therapeutic antibodies
R. Nachbagauer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Laurent Detalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Phase I Study of Ga-68-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
Marleen Keyaerts et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications
Yongzhong Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ
David C. Butler et al.
PLOS ONE (2016)
Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques
Jenny A. Greig et al.
VACCINE (2016)
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
Erin Sparrow et al.
VACCINE (2016)
Detection and manipulation of live antigen-expressing cells using conditionally stable nanobodies
Jonathan C. Y. Tang et al.
ELIFE (2016)
NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
Sandrine Moutel et al.
ELIFE (2016)
The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation
Kankana Bardhan et al.
FRONTIERS IN IMMUNOLOGY (2016)
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic NanobodyA® targeting the DR5 receptor
Kyriakos P. Papadopoulos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model
Wouter Van Overbeke et al.
HUMAN MOLECULAR GENETICS (2015)
Nanobody-based cancer therapy of solid tumors
Marta Kijanka et al.
NANOMEDICINE (2015)
Cell type-specific manipulation with GFP-dependent Cre recombinase
Jonathan C. Y. Tang et al.
NATURE NEUROSCIENCE (2015)
Gene therapy: progress and predictions
Mary Collins et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
Maarten Van Roy et al.
ARTHRITIS RESEARCH & THERAPY (2015)
The therapeutic monoclonal antibody market
Dawn M. Ecker et al.
MABS (2015)
Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics
Maryam Ahmadi et al.
PHARMACEUTICAL RESEARCH (2015)
Molecular Profiling of Neurons Based on Connectivity
Mats I. Ekstrand et al.
CELL (2014)
Adeno-Associated Virus 9-Mediated Airway Expression of Antibody Protects Old and Immunodeficient Mice against Influenza Virus
Virginie S. Adam et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Construction of naive camelids VHH repertoire in phage display-based library
Jamal S. M. Sabir et al.
COMPTES RENDUS BIOLOGIES (2014)
Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
Balaji Balakrishnan et al.
CURRENT GENE THERAPY (2014)
The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency
Simon E. Hufton et al.
PLOS ONE (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
A Nanobody-Based System Using Fluorescent Proteins as Scaffolds for Cell-Specific Gene Manipulation
Jonathan C. Y. Tang et al.
CELL (2013)
Anti-Rotavirus Protein Reduces Stool Output in Infants With Diarrhea: A Randomized Placebo-Controlled Trial
Shafiqul A. Sarker et al.
GASTROENTEROLOGY (2013)
Autoantibodies to Variable Heavy (VH) Chain Ig Sequences in Humans Impact the Safety and Clinical Pharmacology of a VH Domain Antibody Antagonist of TNF-α Receptor 1
M. C. Holland et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Broad protection against influenza infection by vectored immunoprophylaxis in mice
Alejandro B. Balazs et al.
NATURE BIOTECHNOLOGY (2013)
Developing Therapeutic Antibodies for Neurodegenerative Disease
Y. Joy Yu et al.
NEUROTHERAPEUTICS (2013)
Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
Maria P. Limberis et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Angelika Horn et al.
ARTHRITIS AND RHEUMATISM (2012)
Site-Specific Integration by the Adeno-Associated Virus Rep Protein
Alessandra Recchia et al.
CURRENT GENE THERAPY (2012)
Monoclonal antibody therapeutics: history and future
Nicholas A. P. S. Buss et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Intranasal Vaccination with AAV5 and 9 Vectors Against Human Papillomavirus Type 16 in Rhesus Macaques
Karen Nieto et al.
HUMAN GENE THERAPY (2012)
Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies
Shubhada N. Joshi et al.
MABS (2012)
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Damian C. Ekiert et al.
NATURE (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
Lorena Itati Ibanez et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Development of a Liver-specific Tet-On Inducible System for AAV Vectors and Its Application in the Treatment of Liver Cancer
Lucia Vanrell et al.
MOLECULAR THERAPY (2011)
Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules
Anna Hultberg et al.
PLOS ONE (2011)
Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm
Erik Kvam et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Llama-Derived Single-Domain Intrabodies Inhibit Secretion of Hepatitis B Virions in Mice
Benedikte Serruys et al.
HEPATOLOGY (2009)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Adeno-associated virus integration: virus versus vector
R. H. Smith
GENE THERAPY (2008)
An scFv intrabody against the nonamyloid component of α-synuclein reduces intracellular aggregation and toxicity
Sandra M. Lynch et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120
Anna Forsman et al.
JOURNAL OF VIROLOGY (2008)
Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice
Lorena Garaicoechea et al.
JOURNAL OF VIROLOGY (2008)
Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered (vol 103, pg 12993, 2006)
Maria P. Limberis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered
Maria P. Limberis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments
J. M. van der Vaart et al.
VACCINE (2006)
Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library
KYF Yau et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
OJ Müller et al.
NATURE BIOTECHNOLOGY (2003)
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Q Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors
MU Ried et al.
JOURNAL OF VIROLOGY (2002)
Camel heavy-chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen-binding repertoire
VK Nguyen et al.
EMBO JOURNAL (2000)
Share Paper
